tool name

close
tool goes here

Zoloft maker sued over pill's efficacy as antidepressant

The maker of Zoloft is being sued in an unusual case alleging the popular antidepressant has no more benefit than a dummy pill. The federal lawsuit, filed in California, argues that patients who took it should be reimbursed for their costs.

Published: Feb. 1, 2013 at 12:05 a.m. PST
0 comments

The maker of Zoloft is being sued in an unusual case alleging the popular antidepressant has no more benefit than a dummy pill. The federal lawsuit, filed in California, argues that patients who took it should be reimbursed for their costs.

Zoloft’s maker, Pfizer Inc., disagrees. It says clinical studies and the experience of millions of patients and their doctors over two decades prove Zoloft is effective. Pfizer and four psychiatry experts interviewed by The Associated Press call the lawsuit frivolous. But the plaintiff, Laura Plumlee, said Zoloft didn’t help her during three years of treatment. Her attorney, R. Brent Wisner, argues the FDA shouldn’t have approved Zoloft because Pfizer didn’t publish some studies that found the drug about as effective as a placebo.

JOIN THE DISCUSSION | Register here

We welcome comments. Please keep them civil, short and to the point. ALL CAPS, spam, obscene, profane, abusive and off topic comments will be deleted. Repeat offenders will be blocked. Thanks for taking part — and abiding by these simple rules. A thorough explanation of rules of conduct can be found in our Terms of Service. If you have any questions, including why your comment may not be showing immediately after you submit it, be sure to visit the commenting FAQ.

CONTESTS

Similar stories

  • Pfizer plans offering to pare Zoetis stake

    Drugmaker Pfizer Inc. plans to try to sell its controlling stake in its former animal health business, Zoetis Inc., through a voluntary stock exchange with Pfizer shareholders.

  • Pfizer’s profit for 4th quarter beats estimates

    Pfizer Inc. posted sharply higher fourth-quarter net income as tight spending controls and a huge gain from selling its nutrition business helped offset sharply lower sales of cholesterol fighter Lipitor.

  • Pfizer’s quarterly income rises amid falling sales

    Pfizer Inc.’s first-quarter net income rose 53 percent despite falling sales, mainly because the world’s second-largest drugmaker took big charges a year ago. Pfizer’s results fell short of Wall Street’s expectations, and the company lowered its profit and sales forecasts for the year, blaming a sudden worsening of currency exchange rates.

  • Pfizer to offer Viagra for sale through online distribution

    Pfizer Inc. said Monday that it will begin selling its popular erectile dysfunction pill, Viagra, directly to patients on its website.

  • FDA issues warning about Zithromax and heart risks

    The FDA is warning that a widely used antibiotic from Pfizer can cause rare but deadly heart rhythms in some patients. The agency is adding new warnings to the label of Zithromax, which is used to treat bronchitis, pneumonia and other infections.